Vaccination Against Viral Cancer
Author Information
Author(s): Philip G. Stevenson, Janet S. May, Viv Efstathiou, Stacey Connor
Primary Institution: University of Cambridge
Hypothesis
Can vaccination prevent cancers associated with viral infections that may lose their viral genomes over time?
Conclusion
Vaccination with a non-persistent mutant of MuHV-4 provided complete protection against cancers that had lost viral genomes.
Supporting Evidence
- Vaccination with a non-persistent MuHV-4 mutant conferred complete protection against cancer.
- Most cancers analyzed lacked viral genomes despite showing expected genetic changes.
- Over 90% of infected mice developed cancers within 3 months.
Takeaway
This study shows that some cancers caused by viruses can be prevented with vaccines, even if the virus is no longer present in the cancer cells.
Methodology
The study used Cre–lox recombination in mice to trigger mutations in virus-infected cells and analyzed the resulting cancers for viral genome retention.
Limitations
The study primarily focused on a specific mouse model, which may not fully represent human cancers.
Participant Demographics
Mice used in the study included p53flox/flox and K-rasLSL-G12D/+ strains.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website